COMMUNIQUÉS West-GlobeNewswire

Selecta Biosciences Announces Second Quarter 2018 Financial Results and Provides Corporate Update

08/08/2018 - 14:00

Expanded three-month Phase 2 data presented at EULAR 2018 continue to indicate that SEL-212 product profile may provide better and more sustained serum uric acid control, fewer flares and less frequent dosing compared [...]

Genmab Announces Submission of U.S. & EU Regulatory Applications Seeking Approval of DARZALEX® (Daratumumab) Split Dosing Regimen

08/08/2018 - 13:57

Media Release sBLA & Type II Variation submitted to U.S. FDA and the EMA respectively, seeking approval of split dosing regimen for DARZALEX Applications seek to update Prescribing Information and Summary of Product [...]

Affimed Reports Financial Results for Second Quarter 2018 and Operational Progress

08/08/2018 - 13:31

Heidelberg, Germany, August 8, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that harness the power of innate [...]

Cellular Biomedicine Group Reports Second Quarter and First Half 2018 Financial Results and Business Highlights

08/08/2018 - 13:31

SHANGHAI, China and CUPERTINO, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- China Food and Drug Administration (CFDA) Accepts the Company’s Investigational New Drug (IND) Applications for anti-CD19 CAR-T Therapy Targeting [...]

Nevakar and Endo Enter into Exclusive Licensing Agreement for Multiple 505(b)(2) Injectable Products

08/08/2018 - 13:07

BRIDGEWATER, N.J., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Nevakar Inc., a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas, announced today that it recently entered into an [...]

Paratek Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Omadacycline New Drug Applications for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections

08/08/2018 - 13:05

BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

IMV Inc. Announces Q2 2018 Financial Results

08/08/2018 - 13:05

Initiated Trading of Common Shares on Nasdaq; Finalized Corporate Name Change Presented New Positive Data at ASCO on the DECIDE1 trial in Ovarian Cancer Advanced Ongoing Clinical Programs with Merck and Incyte HALIFAX, [...]

Sol-Gel Technologies Reports Second Quarter 2018 Financial Results

08/08/2018 - 13:05

NESS ZIONA, Israel, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]

Unum Therapeutics to Present at Two Upcoming Investor Conferences

08/08/2018 - 13:00

CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ:UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]

Nabriva Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference

08/08/2018 - 13:00

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical stage biopharmaceutical company engaged in the research and development of innovative anti- [...]

Leap Therapeutics Reports Second Quarter 2018 Business Update and Financial Results

08/08/2018 - 13:00

CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported a business update and financial [...]

ProQR Announces Financial Results for the Second Quarter of 2018

08/08/2018 - 13:00

LEIDEN, The Netherlands, Aug. 08, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]

Evogene Reports Second Quarter 2018 Financial Results

08/08/2018 - 13:00

Conference call and webcast, today at 9:00 am Eastern Time REHOVOT, Israel, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science [...]

Pluristem Initiates Two Pivotal Phase III Studies in Israel

08/08/2018 - 13:00

Numerous Clinical Sites in Israel to join sites in the U.S. and Europe for Pivotal Phase III Studies of PLX-PAD Cell Therapy in the Treatment of Critical Limb Ischemia and Muscle Injury Following Hip Fracture HAIFA, [...]

BioNovelus Announces Marvin R Clark Leaving the Board of Directors, and Welcomes Michael D Goodman as New Treasurer and Member of Board of Directors

08/08/2018 - 13:00

Phoenix, Aug. 08, 2018 (GLOBE NEWSWIRE) -- / BioNovelus, Inc. (OTC Pink: ONOV) today announced that Marvin R Clark has stepped down from the Company's board of directors, and as Treasurer for personal reasons, effective [...]

Clearside Biomedical Announces Second Quarter 2018 Financial Results and Provides Corporate Update

08/08/2018 - 13:00

ALPHARETTA, Ga., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

INSYS Therapeutics Reaches Agreement in Principle to Settle Department of Justice Investigation

08/08/2018 - 13:00

Provisional Financial Settlement Terms Are Consistent with Previous Public Statements and Disclosures PHOENIX, Aug. 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, [...]

AC Immune Reports Second Quarter 2018 Financial Results and Corporate Update

08/08/2018 - 10:01

New total cash position of approximately CHF 210 million that is expected to extend cash runway to Q3 2021, excluding potential incoming milestones Financial position strengthened after Q2 close due to issuance of new [...]

“Grindeks” concludes land purchase agreement for innovation centre development

08/08/2018 - 09:42

JSC “Grindeks” announces, it has expanded its territory and acquired a plot of land with buildings located in Riga, Krustpils street 63 for the development of innovation centre. The 92 584-square-meter plot of land in [...]